13
Participants
Start Date
May 28, 2021
Primary Completion Date
February 4, 2025
Study Completion Date
February 4, 2025
Analytical Treatment Interruption
"Participants will stop taking their HIV medication and will stay off HIV medication unless and until the HIV levels in their blood show that their immune system is not controlling their HIV or they meet other ART re-start criteria as noted in section Detailed Description."
Gaborone CRS, Gaborone
Blantyre CRS, Blantyre
Malawi CRS, Lilongwe
CAPRISA eThekwini CRS, Durban
Vulindlela CRS, Durban
Kliptown Soweto CRS, Johannesburg
Ward 21 CRS, Johannesburg
Rustenburg CRS, Rustenburg
Milton Park CRS, Harare
Seke South CRS, Harare
Spilhaus CRS, Harare
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
HIV Prevention Trials Network
NETWORK
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK
HIV Vaccine Trials Network
NETWORK